"Hyperandrogenism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.
| Descriptor ID |
D017588
|
| MeSH Number(s) |
C12.706.316.064.500 C12.706.316.129.750 C13.351.875.253.064.500 C13.351.875.253.129.750 C16.131.939.316.064.500 C16.131.939.316.129.750 C19.391.119.064.500 C19.391.119.129.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperandrogenism".
Below are MeSH descriptors whose meaning is more specific than "Hyperandrogenism".
This graph shows the total number of publications written about "Hyperandrogenism" by people in this website by year, and whether "Hyperandrogenism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperandrogenism" by people in Profiles.
-
Amin M, Gragnoli C. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome. J Ovarian Res. 2023 Nov 22; 16(1):222.
-
Amin M, Gragnoli C. Genome-wide linkage and association study identifies novel genes and pathways implicated in polycystic ovarian syndrome. Eur Rev Med Pharmacol Sci. 2023 Apr; 27(8):3719-3732.
-
Amin M, Horst N, Wu R, Gragnoli C. Oxytocin receptor (OXTR) is a risk gene for polycystic ovarian syndrome. Eur Rev Med Pharmacol Sci. 2023 03; 27(6):2634-2639.
-
Amin M, Perrelli M, Wu R, Gragnoli C. The mineralocorticoid receptor gene (NR3C2) is linked to and associated with polycystic ovarian syndrome in Italian families. Eur Rev Med Pharmacol Sci. 2023 Feb; 27(3):942-948.
-
Legro RS, Kunselman AR, Brzyski RG, Casson PR, Diamond MP, Schlaff WD, Christman GM, Coutifaris C, Taylor HS, Eisenberg E, Santoro N, Zhang H. The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials. 2012 May; 33(3):470-81.
-
Legro RS, Urbanek M, Kunselman AR, Leiby BE, Dunaif A. Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated. Fertil Steril. 2002 Jul; 78(1):51-7.